These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25280791)

  • 1. Neuroleptic malignant syndrome in an elderly patient with normal pressure hydrocephalus overlapping corticobasal degeneration.
    Isik AT; Soysal P
    Am J Alzheimers Dis Other Demen; 2015 Jun; 30(4):417-20. PubMed ID: 25280791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic malignant syndrome in a patient with corticobasal degeneration.
    Lee MJ; Lyoo CH; Lee MS
    J Mov Disord; 2011 Oct; 4(2):73-4. PubMed ID: 24868399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroleptic Malignant Syndrome in Patients With Dementia: Experiences of A Single Memory Clinic.
    Isik AT; Kaya D; Ontan MS; Mutlay F; Bulut EA; Dost FS; Erken N; Aydin AE
    Clin Neuropharmacol; 2023 Nov-Dec 01; 46(6):209-213. PubMed ID: 37962307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic-induced catatonia or a mild form of neuroleptic malignant syndrome?
    Kontaxakis VP; Vaidakis NM; Christodoulou GN; Valergaki HC
    Neuropsychobiology; 1990; 23(1):38-40. PubMed ID: 2280828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catatonia and Neuroleptic Malignant Syndrome in Patients With Cerebral Palsy: Two Case Reports and a Systematic Review of the Literature.
    Barnett BS; Balaji D; Weleff J; Carroll BT
    J Acad Consult Liaison Psychiatry; 2023; 64(3):277-293. PubMed ID: 36586471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and cisternographic differential diagnosis between presenile dementia and Hakim syndrome].
    Kulczycki J; Jedrzejczak T
    Psychiatr Neurol Med Psychol (Leipz); 1984 Nov; 36(11):674-7. PubMed ID: 6522522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
    Khouri C; Planès S; Logerot S; Villier C; Mallaret M
    Encephale; 2016 Jun; 42(3):277-80. PubMed ID: 26923996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catatonic variants, hyperthermic extrapyramidal reactions, and subtypes of neuroleptic malignant syndrome.
    Lee JW
    Ann Clin Psychiatry; 2007; 19(1):9-16. PubMed ID: 17453656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of corticobasal degeneration presenting with alien limb syndrome.
    Tiwari D; Amar K
    Age Ageing; 2008 Sep; 37(5):600-1. PubMed ID: 18515294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroleptic malignant syndrome.
    Kornhuber J; Weller M
    Curr Opin Neurol; 1994 Aug; 7(4):353-7. PubMed ID: 7952245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A disease-specific metabolic brain network associated with corticobasal degeneration.
    Niethammer M; Tang CC; Feigin A; Allen PJ; Heinen L; Hellwig S; Amtage F; Hanspal E; Vonsattel JP; Poston KL; Meyer PT; Leenders KL; Eidelberg D
    Brain; 2014 Nov; 137(Pt 11):3036-46. PubMed ID: 25208922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment.
    Ozen ME; Yumru M; Savas HA; Cansel N; Herken H
    World J Biol Psychiatry; 2007; 8(1):42-4. PubMed ID: 17366349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute catatonic syndrome after neuroleptic malignant syndrome].
    Benjelloun G; Jehel L; Abgrall G; Pelissolo A; Allilaire J
    Encephale; 2005; 31(6 Pt 1):705-9. PubMed ID: 16462690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epilepsy, parkinsonism, and neuroleptic malignant syndrome in a child.
    Martínez HR; Cantú-Martínez L; González HC; Flores Lde L; Villarreal HJ; Onofre-Castillo J
    J Child Neurol; 2006 Dec; 21(12):1073-5. PubMed ID: 17156702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A study of neuroleptic malignant syndrome in the presenium and senium].
    Suzuki I; Honma H; Watanabe N; Matsubara S; Koyama T
    Seishin Shinkeigaku Zasshi; 1998; 100(6):387-97. PubMed ID: 9745353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition, assessment and management of neuroleptic malignant syndrome.
    Khan M; Farver D
    S D J Med; 2000 Sep; 53(9):395-400. PubMed ID: 11016275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal pressure hydrocephalus and dementia--evaluation and treatment.
    Turner DA; McGeachie RE
    Clin Geriatr Med; 1988 Nov; 4(4):815-30. PubMed ID: 3066462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Malignant neuroleptic syndrome in patients with dementia].
    Malling BJ
    Ugeskr Laeger; 1999 Apr; 161(17):2541-2. PubMed ID: 10327877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic interventions in parkinsonism: Corticobasal degeneration.
    Marsili L; Suppa A; Berardelli A; Colosimo C
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S96-100. PubMed ID: 26382843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.